Metraipolis › archive › dc_94b21fb45edd

A phase Ib/II study of modakafusp alfa alone and in combination with pembrolizumab in patients with advanced or metastatic solid tumors — Europe PMC PMID:41445795

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41445795
DOI
10.3389/fonc.2025.1620987
License (as archived)
solo-consultazione
Archived
2026-11-07T19:31:11.008Z
SHA-256 of the archived text
5cd6a7b9fb94042bfe8cbbb33849d1c9af25311eabaf58816297b70c40ec347e
Stable URL of this page
https://metraipolis.com/documento/dc_94b21fb45edd

How to cite

A phase Ib/II study of modakafusp alfa alone and in combination with pembrolizumab in patients with advanced or metastatic solid tumors — Europe PMC PMID:41445795 — Europe PMC (en), https://europepmc.org/article/MED/41445795 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_94b21fb45edd (Metraipolis archive dc_94b21fb45edd, sha256 5cd6a7b9fb94042bfe8cbbb33849d1c9af25311eabaf58816297b70c40ec347e)
BibTeX
@misc{dc94b21fb45edd,
  title = {A phase Ib/II study of modakafusp alfa alone and in combination with pembrolizumab in patients with advanced or metastatic solid tumors — Europe PMC PMID:41445795},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41445795},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_94b21fb45edd; sha256 5cd6a7b9fb94042bfe8cbbb33849d1c9af25311eabaf58816297b70c40ec347e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41445795. Agents can read the archived copy with the MCP tool read_document.